Kieran P. Murphy, Former CEO of GE Healthcare, Joins Gamma Biosciences as Executive Chairman
March 16, 2022
“I couldn’t be more pleased to welcome Kieran aboard as we enter the next phase of our journey”, said
“I am delighted to have the opportunity to join the Gamma team and to work closely with Matt and the board. I believe the company is building a portfolio of industry-leading technologies addressing a number of critical challenges in the rapidly growing market for next-generation therapies,” commented
“We are thrilled to have Kieran joining Gamma at this very exciting moment for the company. We have long admired Kieran’s strategic instincts, operating rigor, and entrepreneurial vigor, and believe his long history of leadership, experience, and insights will prove to be tremendously helpful to Gamma,” said Kugan Sathiyanandarajah, Managing Director at KKR and Head of
About Gamma Biosciences
Gamma Biosciences is a leading life sciences company providing products and services to support the development and manufacturing of advanced biologic therapies. We are committed to advancing the science and art of bioprocessing by delivering market-ready innovation and expertise to our customers, mainly biopharmaceutical developers and contract development and manufacturing companies, helping them bring therapies to patients more quickly and efficiently with the highest standards of quality. Gamma is a global company with offices and major manufacturing facilities in
About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of
View source version on businesswire.com: https://www.businesswire.com/news/home/20220316005514/en/
Media Contacts
Alastair Elwen /
Finsbury Glover Hering
Telephone: +44 20 7251 3801
Email: KKR-LON@finsbury.com
Source: KKR
Back to Press Releases
Media Contacts
Americas
Miles Radcliffe-Trenner
Telephone: +1 (212) 750-8300
Email: media@kkr.com
Investor Relations
Craig Larson
Telephone: +1 (877) 610-4910
Outside US: +1 (212) 230-9410
Facsimile: +1 (212) 750-0003
Email: Investor-Relations@kkr.com